Steris PLC (STE)
232.69
+1.96
(+0.85%)
USD |
NYSE |
May 17, 16:00
232.74
+0.05
(+0.02%)
After-Hours: 20:00
Steris Enterprise Value: 25.91B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 25.91B |
| May 16, 2024 | 25.71B |
| May 15, 2024 | 26.18B |
| May 14, 2024 | 26.23B |
| May 13, 2024 | 25.89B |
| May 10, 2024 | 25.77B |
| May 09, 2024 | 25.24B |
| May 08, 2024 | 23.67B |
| May 07, 2024 | 23.95B |
| May 06, 2024 | 23.62B |
| May 03, 2024 | 23.45B |
| May 02, 2024 | 23.29B |
| May 01, 2024 | 23.17B |
| April 30, 2024 | 23.13B |
| April 29, 2024 | 23.21B |
| April 26, 2024 | 23.06B |
| April 25, 2024 | 22.83B |
| April 24, 2024 | 22.95B |
| April 23, 2024 | 23.27B |
| April 22, 2024 | 22.76B |
| April 19, 2024 | 22.63B |
| April 18, 2024 | 22.76B |
| April 17, 2024 | 22.70B |
| April 16, 2024 | 22.58B |
| April 15, 2024 | 22.80B |
| Date | Value |
|---|---|
| April 12, 2024 | 23.07B |
| April 11, 2024 | 23.30B |
| April 10, 2024 | 23.59B |
| April 09, 2024 | 24.13B |
| April 08, 2024 | 23.93B |
| April 05, 2024 | 24.01B |
| April 04, 2024 | 24.00B |
| April 03, 2024 | 24.32B |
| April 02, 2024 | 24.28B |
| April 01, 2024 | 24.75B |
| March 31, 2024 | 25.13B |
| March 28, 2024 | 25.34B |
| March 27, 2024 | 25.41B |
| March 26, 2024 | 25.02B |
| March 25, 2024 | 24.93B |
| March 22, 2024 | 25.76B |
| March 21, 2024 | 25.57B |
| March 20, 2024 | 26.18B |
| March 19, 2024 | 25.87B |
| March 18, 2024 | 25.85B |
| March 15, 2024 | 25.86B |
| March 14, 2024 | 26.01B |
| March 13, 2024 | 26.23B |
| March 12, 2024 | 26.23B |
| March 11, 2024 | 26.23B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.09B
Minimum
Mar 23 2020
28.06B
Maximum
Apr 20 2022
20.27B
Average
21.51B
Median
Enterprise Value Benchmarks
| Edwards Lifesciences Corp | 52.68B |
| ResMed Inc | 32.88B |
| Align Technology Inc | 19.54B |
| ThermoGenesis Holdings Inc | 8.406M |
| Nutriband Inc | 48.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.377M |
| Revenue (Quarterly) | 1.419B |
| Total Expenses (Quarterly) | 1.173B |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 41.07% |
| Profit Margin (Quarterly) | -0.10% |
| Earnings Yield | 1.64% |
| Operating Earnings Yield | 3.62% |
| Normalized Earnings Yield | 2.398 |